Class II-selective histone deacetylase inhibitors. Part 2: alignment-independent GRIND 3-D QSAR, homology and docking studies
- PMID: 17698257
- DOI: 10.1016/j.ejmech.2007.05.004
Class II-selective histone deacetylase inhibitors. Part 2: alignment-independent GRIND 3-D QSAR, homology and docking studies
Abstract
(Aryloxopropenyl)pyrrolyl hydroxamates were recently reported by us as first examples of class II-selective HDAC inhibitors and can be useful tools to probe the biology of such enzymes. Molecular modelling and 3-D QSAR studies have been performed on a series of 25 (aryloxopropenyl)pyrrolyl hydroxamates to gain insights about their activity and selectivity against both maize HD1-B and HD1-A, two enzymes homologous of mammalian class I and class II HDACs, respectively. The studies have been accomplished by calculating alignment-independent descriptors (GRIND descriptors) using the ALMOND software. Highly descriptive and predictive 3-D QSAR models were obtained using either class I or class II inhibitory activity displaying r(2)/q(2) values of 0.96/0.81 and 0.98/0.85 for HD1-B and HD1-A, respectively. A deeper inspection revealed that in general a bent molecular shape structure is a prerequisite for HD1-A-selective inhibitory activity, while straight shape molecular skeleton leads to selective HD1-B compounds. The same conclusions could be achieved by molecular docking studies of the most selective inhibitors.
Similar articles
-
New pyrrole-based histone deacetylase inhibitors: binding mode, enzyme- and cell-based investigations.Int J Biochem Cell Biol. 2009 Jan;41(1):235-47. doi: 10.1016/j.biocel.2008.09.002. Epub 2008 Sep 12. Int J Biochem Cell Biol. 2009. PMID: 18834955
-
Discovery of (aryloxopropenyl)pyrrolyl hydroxyamides as selective inhibitors of class IIa histone deacetylase homologue HD1-A.J Med Chem. 2003 Nov 6;46(23):4826-9. doi: 10.1021/jm034167p. J Med Chem. 2003. PMID: 14584932
-
Docking of hydroxamic acids into HDAC1 and HDAC8: a rationalization of activity trends and selectivities.J Chem Inf Model. 2009 Dec;49(12):2774-85. doi: 10.1021/ci900288e. J Chem Inf Model. 2009. PMID: 19947584
-
Zn(II)-dependent histone deacetylase inhibitors: suberoylanilide hydroxamic acid and trichostatin A.Int J Biochem Cell Biol. 2009 Apr;41(4):736-9. doi: 10.1016/j.biocel.2008.05.026. Epub 2008 Aug 3. Int J Biochem Cell Biol. 2009. PMID: 18725319 Review.
-
Towards selective inhibition of histone deacetylase isoforms: what has been achieved, where we are and what will be next.ChemMedChem. 2014 Mar;9(3):523-6. doi: 10.1002/cmdc.201300413. ChemMedChem. 2014. PMID: 24730063 Review.
Cited by
-
Synthesis of Multi-Substituted Pyrrole Derivatives Through [3+2] Cycloaddition with Tosylmethyl Isocyanides (TosMICs) and Electron-Deficient Compounds.Molecules. 2018 Oct 17;23(10):2666. doi: 10.3390/molecules23102666. Molecules. 2018. PMID: 30336556 Free PMC article. Review.
-
Computer-Aided Drug Design in Epigenetics.Front Chem. 2018 Mar 12;6:57. doi: 10.3389/fchem.2018.00057. eCollection 2018. Front Chem. 2018. PMID: 29594101 Free PMC article. Review.
-
Identification of NuRSERY, a new functional HDAC complex composed by HDAC5, GATA1, EKLF and pERK present in human erythroid cells.Int J Biochem Cell Biol. 2014 May;50:112-22. doi: 10.1016/j.biocel.2014.02.019. Epub 2014 Mar 1. Int J Biochem Cell Biol. 2014. PMID: 24594363 Free PMC article.
-
Exploration of Structure-Activity Relationship Using Integrated Structure and Ligand Based Approach: Hydroxamic Acid-Based HDAC Inhibitors and Cytotoxic Agents.Turk J Pharm Sci. 2023 Aug 22;20(4):270-284. doi: 10.4274/tjps.galenos.2022.12269. Turk J Pharm Sci. 2023. PMID: 37606012 Free PMC article.
-
Predictive QSAR workflow for the in silico identification and screening of novel HDAC inhibitors.Mol Divers. 2009 Aug;13(3):301-11. doi: 10.1007/s11030-009-9115-2. Epub 2009 Feb 10. Mol Divers. 2009. PMID: 19205914
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Chemical Information